Please assess the completion status of the following clinical trial:

Trial Title: Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* All residents of the nursing home facility, (M/F) 65 years or above, who have recently tested positive through Ohio's PARRT Program are eligible~* Resident must submit weekly nasal swab sample per nursing home COVID testing guidelines~* Clinical suspicion of a new episode of acute respiratory tract infection.~* Laboratory confirmed SARS-CoV-2 infection by either a laboratory test, PCR or any other commercial or public health test~Exclusion Criteria:~* Nursing home residents that are not taking part regularly in weekly screening for SARS-COV-2 or residents that test negative through Ohio's PARRT program cannot be included as part of study analyses~* Residents on hospice, residents currently intubated, residents with scheduled transfer to another nursing home facility will not be included in study analyses

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Patients with New Cases of SARS-CoV-2 (Type: None): Newly recruited residents who have been identified as positive through Ohio's Post-Acute Regional Rapid Testing (PARRT) Program will undergo at at least 4 weeks, but no more than 8 weeks, of nasal swab and exhaled breathe particles specimen collection for Covid testing. Previously enrolled residents will submit weekly collections of nasal swab specimens and exhaled breathe particles once they exhibit respiratory-related symptoms, or once a test is ordered by the provider for suspicion of exposure. Collection will continue until these subjects fulfill their 8 weeks of testing.
- Patients without SARS-CoV-2 (Type: None): This cohort will consist of previously enrolled residents who submitted nasal swabs and exhaled breathe particles for Covid testing once a week for 8 weeks. The patients will have been identified as negative for a SARS-CoV-2 infection each week.

Based on this trial design, predict the completion outcome and termination type (if applicable).